Genomic landscape of the immune microenvironments of brain metastases in breast cancer.

Wei-Cheng LuHui XieCe YuanJin-Jiang LiZhao-Yang LiAn-Hua Wu

Published in: Journal of translational medicine (2020)

Targeting macrophages or plasma cells may be new strategies for immunotherapy of breast cancer with brain metastases. THY1 and NEU2 may be potential therapeutic targets for breast cancer with brain metastases, and THY1, CD1B and DOCK2 may serve as potential prognostic markers for improvement of brain metastases survival.

Keyphrases

brain metastases
small cell lung cancer
induced apoptosis
human health
cell cycle arrest
copy number
risk assessment
young adults
cell death
free survival
childhood cancer